Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGS
6726
DELISTED
PlayAGS
AGS
| $1.09M | ﹤0.01% |
210,919
-21,626
| -9% | -$126K |
|
6727
CALL
Lindsay Corp
LNN
$1.15B
| $1.09M | ﹤0.01% |
8,200
-200
| -2% | -$26.5K |
|
6728
Direxion Daily Dow Jones Internet Bear 3X ETF
WEBS
$7.46M
| $1.09M | ﹤0.01% |
2,115
-12
| -0.6% | -$4.86K |
|
6729
CALL
BJ's Restaurants
BJRI
$1.39B
| $1.09M | ﹤0.01% |
50,200
+15,100
| +43% | +$389K |
|
|
VPU
6730
Vanguard Utilities ETF
VPU
$8.6B
| $1.09M | ﹤0.01% |
7,132
-1,090
| -13% | -$172K |
|
6731
Liquidity Services
LQDT
$1.35B
| $1.09M | ﹤0.01% |
+80,843
| New | +$1.19M |
|
|
LFTR
6732
PUT
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
| $1.09M | ﹤0.01% |
109,600
+87,100
| +387% | +$860K |
|
6733
Harmonic Inc
HLIT
$1.39B
| $1.08M | ﹤0.01% |
125,135
-28,493
| -19% | -$257K |
|
6734
Globus Medical
GMED
$11.7B
| $1.08M | ﹤0.01% |
19,291
-73,087
| -79% | -$4.8M |
|
6735
PUT
Andersons Inc
ANDE
$2.32B
| $1.08M | ﹤0.01% |
32,800
-17,300
| -35% | -$736K |
|
6736
CALL
Triumph Financial Inc
TFIN
$1.83B
| $1.08M | ﹤0.01% |
17,300
-300
| -2% | -$21.3K |
|
|
BWIN
6737
Baldwin Insurance Group
BWIN
$3B
| $1.08M | ﹤0.01% |
44,814
-405,386
| -90% | -$9.86M |
|
6738
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.74B
| $1.08M | ﹤0.01% |
22,516
+11,302
| +101% | +$569K |
|
|
GOGL
6739
PUT
DELISTED
Golden Ocean Group
GOGL
| $1.08M | ﹤0.01% |
92,900
+39,400
| +74% | +$528K |
|
6740
Petco
WOOF
$797M
| $1.08M | ﹤0.01% |
73,255
-840,322
| -92% | -$15.3M |
|
|
RVNC
6741
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.08M | ﹤0.01% |
78,100
-30,300
| -28% | -$466K |
|
|
MCHB
6742
Mechanics Bancorp
MCHB
$3.71B
| $1.08M | ﹤0.01% |
+31,074
| New | +$1.25M |
|
6743
Radware
RDWR
$1.2B
| $1.08M | ﹤0.01% |
49,791
-142,766
| -74% | -$3.74M |
|
|
AVYA
6744
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $1.08M | ﹤0.01% |
481,300
-95,000
| -16% | -$679K |
|
6745
Fidelity MSCI Industrials Index ETF
FIDU
$2.36B
| $1.08M | ﹤0.01% |
23,838
-23,344
| -49% | -$1.14M |
|
6746
John Hancock Multifactor Small Cap ETF
JHSC
$739M
| $1.08M | ﹤0.01% |
36,828
+15,141
| +70% | +$479K |
|
|
LOUP
6747
Innovator Deepwater Frontier Tech ETF
LOUP
$219M
| $1.08M | ﹤0.01% |
+36,282
| New | +$1.3M |
|
6748
Workiva
WK
$3.91B
| $1.08M | ﹤0.01% |
+16,311
| New | +$1.36M |
|
|
NWLI
6749
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.08M | ﹤0.01% |
5,311
+471
| +10% | +$96.4K |
|
6750
CALL
AngloGold Ashanti
AU
$49.6B
| $1.07M | ﹤0.01% |
72,700
-581,500
| -89% | -$11M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.